Cresset Asset Management, LLC Fulgent Genetics, Inc. Transaction History

Cresset Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$21.55 - $29.29 $842,001 - $1.14 Million	-39,072 Reduced 72.03%	15,174 $329,000
Q4 2023 Feb 14, 2024	BUY	$23.64 - $30.27 $207,913 - $266,224	8,795 Added 19.35%	54,246 $1.57 Million
Q3 2023 Nov 14, 2023	BUY	$26.74 - $40.81 $117,736 - $179,686	4,403 Added 10.73%	45,451 $1.22 Million
Q2 2023 Aug 14, 2023	BUY	$28.52 - $40.7 $1.17 Million - $1.67 Million	41,048 New	41,048 $1.52 Million
Q1 2022 May 16, 2022	SELL	$49.85 - $96.11 $315,301 - $607,895	-6,325 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$77.3 - $105.0 $488,922 - $664,125	6,325 New	6,325 $637,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.